Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7040)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2017 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fujii M, Nishida A, Imaeda H, Ohno M, Nishino K, Sakai S, Inatomi O, Bamba S, Kawahara M, Shimizu T, Andoh A. Expression of Interleukin-26 is upregulated in inflammatory bowel disease. World J Gastroenterol 2017; 23(30): 5519-5529 [PMID: 28852311 DOI: 10.3748/wjg.v23.i30.5519] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i30/5519.htm |
| Number | Citing Articles |
| 1 |
Bjoern-Thore Hansen, Gregor Maschkowitz, Rainer Podschun, Helmut Fickenscher. The Kinocidin Interleukin-26 Shows Immediate Antimicrobial Effects Even to Multi-resistant Isolates. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.757215
|
| 2 |
G. P. Suchitha, Shobha Dagamajalu, Thottethodi Subrahmanya Keshava Prasad, Rex Devasahayam Arokia Balaya. A Comprehensive Network Map of Interleukin-26 Signaling Pathway. Journal of Interferon & Cytokine Research 2024; doi: 10.1089/jir.2024.0026
|
| 3 |
Élodie Beaumont, Vincent Larochette, Laurence Preisser, Charline Miot, Pascale Pignon, Simon Blanchard, Björn-Thore Hansen, Jonathan Dauvé, Caroline Poli, Minna M. Poranen, Patricia Lamourette, Marc Plaisance, Alain Morel, Helmut Fickenscher, Pascale Jeannin, Philippe Roingeard, Yves Delneste. IL-26 inhibits hepatitis C virus replication in hepatocytes. Journal of Hepatology 2022; 76(4): 822 doi: 10.1016/j.jhep.2021.12.011
|
| 4 |
Jing Bao, Zhigang Lv, Saibin Wang. RETRACTED: Anti-angiogenic effect of Interleukin-26 in oxygen-induced retinopathy mice via inhibiting NFATc1-VEGF pathway. Biochemical and Biophysical Research Communications 2018; 499(4): 849 doi: 10.1016/j.bbrc.2018.04.004
|
| 5 |
Jian-Heng Bao, Hai-Tao Shang, Cheng-Fei Hao, Jun-Jian Liu, Shu-Wang Han, De-Lin Zhang, Zhong-Lian Li. Prognostic value of IL-26 level in hepatocellular carcinoma tissue in postoperative patients with hepatitis B related hepatocellular carcinoma. World Chinese Journal of Digestology 2021; 29(10): 511 doi: 10.11569/wcjd.v29.i10.511
|
| 6 |
Lize Wu, Ziwei Xue, Siqian Jin, Jinchun Zhang, Yixin Guo, Yadan Bai, Xuexiao Jin, Chaochen Wang, Lie Wang, Zuozhu Liu, James Q Wang, Linrong Lu, Wanlu Liu. huARdb: human Antigen Receptor database for interactive clonotype-transcriptome analysis at the single-cell level. Nucleic Acids Research 2022; 50(D1): D1244 doi: 10.1093/nar/gkab857
|
| 7 |
Alessia Baldo, Jeremy Di Domizio, Ahmad Yatim, Sophie Vandenberghe-Dürr, Raphael Jenelten, Anissa Fries, Lorenzo Grizzetti, François Kuonen, Carle Paul, Robert L. Modlin, Curdin Conrad, Michel Gilliet. Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26. Journal of Experimental Medicine 2024; 221(5) doi: 10.1084/jem.20231464
|
| 8 |
Isabelle M. Weishaar, Rebecca S. Young, Brody M. Wiles, Dennis W. McGee. The Effect of IL-26 on TNF-α-Induced CXCL8 Responses by Colonic Epithelial Cell Lines. Immunological Investigations 2019; 48(8): 822 doi: 10.1080/08820139.2019.1594247
|
| 9 |
Vincent Larochette, Charline Miot, Caroline Poli, Elodie Beaumont, Philippe Roingeard, Helmut Fickenscher, Pascale Jeannin, Yves Delneste. IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00204
|
| 10 |
Saeideh Momtaz, Maryam Navabakhsh, Negin Bakouee, Mustafa Dehnamaki, Mahban Rahimifard, Maryam Baeeri, Alireza Abdollahi, Mohammad Abdollahi, Mohamad Hosein Farzaei, Amir Hossein Abdolghaffari. Cinnamaldehyde targets TLR-4 and inflammatory mediators in acetic-acid induced ulcerative colitis model. Biologia 2021; 76(6): 1817 doi: 10.1007/s11756-021-00725-w
|
| 11 |
Dongjuan Song, Lijie Lai, Juntao Lu, Jinlu Tong, Zhihua Ran. Interleukin-26 Expression in Inflammatory Bowel Disease and Its Immunoregulatory Effects on Macrophages. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.797135
|
| 12 |
Michel Gilliet, Robert L. Modlin. Immunobiology of IL-26. Journal of Investigative Dermatology 2024; doi: 10.1016/j.jid.2023.10.038
|
| 13 |
Liwen Luo, Li Jiang, Zhiqiang Tian, Xinqi Zhang. The serum interleukin-26 level is a potential biomarker for chronical hepatitis B. Medicine 2020; 99(1): e18462 doi: 10.1097/MD.0000000000018462
|
| 14 |
Arezoo Gowhari Shabgah, Walid Kamal Abdelbasset, Heshu Sulaiman Rahman, Dmitry O. Bokov, Wanich Suksatan, Lakshmi Thangavelu, Majid Ahmadi, Mahsa Malekahmadi, Seyed Mohammad Gheibihayat, Jamshid Gholizadeh Navashenaq. A comprehensive review of IL‐26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections. Immunology 2022; 165(1): 44 doi: 10.1111/imm.13424
|
| 15 |
Lu Chen, Guangcong Ruan, Yi Cheng, Ailin Yi, Dongfeng Chen, Yanling Wei. The role of Th17 cells in inflammatory bowel disease and the research progress. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1055914
|
| 16 |
Daniele Corridoni, Agne Antanaviciute, Tarun Gupta, David Fawkner-Corbett, Anna Aulicino, Marta Jagielowicz, Kaushal Parikh, Emmanouela Repapi, Steve Taylor, Dai Ishikawa, Ryo Hatano, Taketo Yamada, Wei Xin, Hubert Slawinski, Rory Bowden, Giorgio Napolitani, Oliver Brain, Chikao Morimoto, Hashem Koohy, Alison Simmons. Single-cell atlas of colonic CD8+ T cells in ulcerative colitis. Nature Medicine 2020; 26(9): 1480 doi: 10.1038/s41591-020-1003-4
|
| 17 |
Vladana Domazetovic, Andrea Giovanni Bonanomi, Maria Stio, Maria Teresa Vincenzini, Teresa Iantomasi. Resveratrol decreases TNFα-induced ICAM-1 expression and release by Sirt-1-independent mechanism in intestinal myofibroblasts. Experimental Cell Research 2019; 382(2): 111479 doi: 10.1016/j.yexcr.2019.06.024
|
| 18 |
Jan Hendrik Niess, Petr Hruz, Tanay Kaymak. The Interleukin-20 Cytokines in Intestinal Diseases. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01373
|
| 19 |
Beatriz Orts, Ana Gutierrez, Lucía Madero, Laura Sempere, Ruben Frances, Pedro Zapater. Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn’s Disease. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.795272
|
| 20 |
E. Scala, R. Di Caprio, S. Cacciapuoti, G. Caiazzo, A. Fusco, E. Tortorella, G. Fabbrocini, A. Balato. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin‐26. British Journal of Dermatology 2019; 181(5): 1038 doi: 10.1111/bjd.17854
|
| 21 |
Hugo Bottois, Marjolaine Ngollo, Nassim Hammoudi, Tristan Courau, Julie Bonnereau, Victor Chardiny, Céline Grand, Brice Gergaud, Matthieu Allez, Lionel Le Bourhis. KLRG1 and CD103 Expressions Define Distinct Intestinal Tissue-Resident Memory CD8 T Cell Subsets Modulated in Crohn's Disease. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00896
|
| 22 |
Zhi-Feng Xi, Seogsong Jeong, Chen-Chen Wang, Hong-Jie Li, Han Guo, Jie Cai, Jia-Xin Li, Xiao-Ni Kong, Ying Tong, Qiang Xia. Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection. Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 242 doi: 10.1016/j.hbpd.2019.03.006
|
| 23 |
Mohamed A. Morsy, Sumeet Gupta, Anroop B. Nair, Katharigatta N. Venugopala, Khaled Greish, Mahmoud El-Daly. Protective Effect of Spirulina platensis Extract against Dextran-Sulfate-Sodium-Induced Ulcerative Colitis in Rats. Nutrients 2019; 11(10): 2309 doi: 10.3390/nu11102309
|
| 24 |
Ryo Hatano, Takumi Itoh, Haruna Otsuka, Sayo Okamoto, Eriko Komiya, Satoshi Iwata, Thomas M. Aune, Nam H. Dang, Kyoko Kuwahara-Arai, Kei Ohnuma, Chikao Morimoto. Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis. mAbs 2019; 11(8): 1428 doi: 10.1080/19420862.2019.1654305
|
| 25 |
Shixian Hu, Werna T. Uniken Venema, Harm-Jan Westra, Arnau Vich Vila, Ruggero Barbieri, Michiel D. Voskuil, Tjasso Blokzijl, Bernadien H. Jansen, Yanni Li, Mark J. Daly, Ramnik J. Xavier, Gerard Dijkstra, Eleonora A. Festen, Rinse K. Weersma. Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-21458-z
|
| 26 |
Irina Turchin, Marc Bourcier. The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases. Advances in Therapy 2022; 39(10): 4474 doi: 10.1007/s12325-022-02241-y
|